Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.

Drugs & aging - 1 Mar 2013

Uusvaara Juho, Pitkala Kaisu H, Kautiainen Hannu, Tilvis Reijo S, Strandberg Timo E

Abstract excerpt

BACKGROUND: Many potentially inappropriate drugs prescribed to older people have anticholinergic properties and may therefore be harmful. Drugs with anticholinergic properties (DAPs) are associated with cognitive decline. OBJECTIVE: Our aim was to study the profile of various cognitive functions related to current use of DAPs. METHODS: A cross-sectional study was conducted in Helsinki, Finland, and included 400...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Cognition Disorders

Share to Cross-Sectional Studies

Share to Finland

Share to Memory

Share to Psychological Tests

Source

Identifiers

PMID: 23361527
DOI: 10.1007/s40266-013-0055-2

Genes

DAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.PMID 23361527Read ↗

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.Semantic proximity Read ↗

[Effect of anticholinergic drugs on cognitive impairment in the elderly].Semantic proximity Read ↗

Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.Semantic proximity Read ↗

Apolipoprotein E ε4 Modifies the Effect of Possible Anticholinergic Drugs on Incident Dementia: The Shanghai Aging Study.Semantic proximity Read ↗

Anticholinergic Drug Burden and Risk of Incident MCI and Dementia: A Population-based Study.Semantic proximity Read ↗

Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.Semantic proximity Read ↗

Potentially inappropriate medications related to two-year progression of mild cognitive impairment and dementiaSemantic proximity Read ↗

Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-world DataSemantic proximity Read ↗

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserinSemantic proximity Read ↗

The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.Semantic proximity Read ↗

Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disordersSemantic proximity Read ↗

Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.